Handelsavisen
prelaunch
Companies Healthcare 9340.T
93
9340.T Tokyo Stock Exchange Medical Equipment, Supplies & Distribution

Aso International Inc

¥685,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
3,53 %
Op margin
17,1 %
ROE
4,0 %
Net margin
11,7 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Aso International Inc provides medical equipment, supplies, and distribution services in the healthcare sector.

Business. Aso International Inc (9340.T) is a Japanese healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates primarily through the sale of medical products and is headquartered in Japan. It is listed on the Tokyo Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
4,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 9340.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 9340.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Aso International Inc (9340.T) is a Japanese healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates primarily through the sale of medical products and is headquartered in Japan. It is listed on the Tokyo Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Aso International Inc maintains a strong liquidity position, with a current ratio of 7.01, indicating a high ability to meet short-term obligations. The company holds JPY 1,873,428,000 in cash and equivalents, representing 64.6% of its total assets, and has no long-term debt, which further supports its liquidity profile. This liquidity is supported by a total equity of JPY 2,588,630,000, with total liabilities at JPY 369,765,000, resulting in a debt-to-equity ratio of 0.

    In terms of profitability, Aso International Inc reports a return on equity (ROE) of 3.97% and a return on assets (ROA) of 3.47%. These figures are below the industry median for ROE and ROA in the Medical Equipment, Supplies & Distribution sector, suggesting that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided in the available data. This lack of geographic diversification may expose the company to regional economic or regulatory risks, though the extent of such exposure is not quantified in the available data.

    Looking ahead, Aso International Inc is projected to grow its revenue from JPY 8,743,350,000 in the current fiscal year to JPY 4,100,000,000 in the next fiscal year, representing a decline of 53.0%. This significant drop in revenue expectations may be attributed to market saturation, competitive pressures, or a shift in demand for its products and services.

    The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The absence of long-term debt and the high cash reserves reduce the likelihood of financial distress. However, the potential for dilution remains low, as the number of shares outstanding has not changed between basic and diluted shares.

    Recent events, including analyst estimates and actual performance, indicate a mixed outlook. The last actual EPS was 44.90 JPY, compared to a mean estimate of 50.00 JPY, suggesting a slight underperformance. Similarly, the last actual revenue of JPY 3,796,450,000 fell short of the mean estimate of JPY 4,100,000,000, indicating a need for the company to address potential operational or market challenges.

    Key takeaways
    • Aso International Inc has a strong liquidity position with a current ratio of 7.01 and no long-term debt.
    • The company's ROE and ROA are below industry medians, indicating underperformance in capital efficiency and asset utilization.
    • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
    • Analyst estimates suggest a significant decline in revenue for the next fiscal year, from JPY 8.74 billion to JPY 4.1 billion.
    • The company faces low liquidity and dilution risk, with no immediate filing-based flags detected.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Aso International maintains a zero long-term debt balance, eliminating interest expense and financial distress risk.

    Revenue grew to 3.8 billion JPY in FY2025, demonstrating consistent top-line expansion over recent periods.

    Return on equity of 3.97% outperforms the 1.42% median return for the broader medical equipment sector.

    BEAR CASE · 1

    The four-year revenue CAGR of -0.6% suggests long-term top-line stagnation despite recent positive trends.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-13
    Q4 2025 · Quarter highlights

    Revenue ¥1.02B, +7,7% YoY; Operating income +11,6% YoY.

    Revenue¥1.02B+7,7 % YoY
    Operating income¥169.9M+11,6 % YoY
    Net income¥125.8M+2,9 % YoY
    Free cash flow
    EPS
    Operating cash flow¥193.8M−13,0 % YoY
    Financials
    Income statement
    Revenue¥1.02B
    Gross profit¥439.9M
    Operating income¥169.9M
    Net income¥125.8M
    Margins
    Gross margin43.1%
    Operating margin16.6%
    Net margin12.3%
    FCF margin
    Balance sheet
    Total assets¥3.49B
    Total liabilities¥547.2M
    Total equity¥2.94B
    Cash & equivalents¥1.40B
    Long-term debt¥0.00
    Cash flow
    Operating cash flow¥193.8M
    CapEx-¥9.8M
    Free cash flow
    SBC
    P&L flow · revenue → net income
    Revenue ¥1.02BOperating costs ¥850.7MTax ¥44.1MNet income ¥125.8M
    Highlights
    • Revenue ¥1.02B, +7,7% YoY
    • Operating income +11,6% YoY
    • Net income +2,9% YoY
    • Net margin 12.3%

    Valuation TTM

    Market price
    ¥685,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥2.59B
    Net cash
    ¥1.87B
    Current ratio
    7.0
    Debt / equity
    0.0
    ROA
    3.5%
    ROE
    4.0%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    50,00
    Predicted surprise
    0,00
    Beat probability
    45 %
    Analysts
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-11 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate50,00
    Revenueno estimateno estimate4,1B JPY
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in JPY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data
    EPS surprise
    −10,2 %
    reported vs consensus · miss
    Revenue surprise
    −7,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin17,1 %Above P75
    Net Margin11,8 %Above P75
    ROE4,0 %Above median
    D/E0,00Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Return On Assets
      net_income / total_assets
    Source documents
    • Aso International Inc Market data — financials · 2026-05-27
    • Aso International Inc Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    9340.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    PredictorBeat prob45 %Surprise0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-02-13 11:00 UTCEARNINGSQuarterly results — Q4 2025 Revenue JPY 1.02B · Net JPY 125.8M
    2025-11-13 11:00 UTCEARNINGSQuarterly results — Q3 2025 Revenue JPY 1.00B · Net JPY 110.0M
    2025-08-08 11:00 UTCEARNINGSQuarterly results — Q2 2025 Revenue JPY 979.5M · Net JPY 131.6M
    2025-08-08 11:00 UTCEARNINGSAnnual results — FY 2025 Revenue JPY 3.80B · Net JPY 438.6M
    2025-05-13 11:00 UTCEARNINGSQuarterly results — Q1 2025 Revenue JPY 952.9M · Net JPY 106.2M
    2025-02-13 11:00 UTCEARNINGSQuarterly results — Q4 2024 Revenue JPY 947.7M · Net JPY 122.2M
    2024-11-13 11:00 UTCEARNINGSQuarterly results — Q3 2024 Revenue JPY 916.3M · Net JPY 78.5M
    2024-08-13 11:30 UTCEARNINGSQuarterly results — Q2 2024 Revenue JPY 955.1M · Net JPY 164.3M
    2024-08-13 11:30 UTCEARNINGSAnnual results — FY 2024 Revenue JPY 3.54B · Net JPY 386.4M
    2024-05-13 11:30 UTCEARNINGSQuarterly results — Q1 2024 Revenue JPY 874.3M · Net JPY 102.7M
    2023-08-14 11:30 UTCEARNINGSAnnual results — FY 2023 Revenue JPY 3.19B · Net JPY 338.2M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage